Details for New Drug Application (NDA): 212383
✉ Email this page to a colleague
The generic ingredient in DAPSONE is dapsone. There are eight drug master file entries for this compound. Twenty-seven suppliers are listed for this compound. Additional details are available on the dapsone profile page.
Suppliers and Packaging for NDA: 212383
Tradename | Generic Name | Dosage | NDA | Application Type | Supplier | National Drug Code | Package Code | Package |
---|---|---|---|---|---|---|---|---|
DAPSONE | dapsone | GEL;TOPICAL | 212383 | ANDA | Encube Ethicals Private Limited | 21922-018 | 21922-018-07 | 1 TUBE in 1 CARTON (21922-018-07) / 60 g in 1 TUBE |
DAPSONE | dapsone | GEL;TOPICAL | 212383 | ANDA | Encube Ethicals Private Limited | 21922-018 | 21922-018-08 | 1 TUBE in 1 CARTON (21922-018-08) / 90 g in 1 TUBE |
Profile for product number 001
Active Rx/OTC/Discontinued: | RX | Dosage: | GEL;TOPICAL | Strength | 5% | ||||
Approval Date: | Oct 13, 2023 | TE: | AB | RLD: | No |
Complete Access Available with Subscription